Главная › Рак молочной железы › Нью-Джерси

Клинические исследования Рак молочной железы в штате Нью-Джерси

93 исследований по теме Рак молочной железы ищут участников в центрах в штате Нью-Джерси.

Города в штате Нью-Джерси

Официальный текст исследования (на английском)

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

MD Anderson Cancer Center At Cooper, Camden
Summit Health, Florham Park
The Valley Hospital, Ridgewood

Набор участниковФаза 3

Возраст от 18 до 100 · Любой пол · Обновлено 2 окт. 2026 г. · NCT05827081

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Набор участниковФаза 2

Возраст от 18 лет · Любой пол · Обновлено 2 окт. 2026 г. · NCT05534438

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Englewood Hospital and Medical Center, Englewood
Hackettstown Medical Center, Hackettstown
Morristown Medical Center, Morristown
и еще 6

Набор участниковНаблюдательное исследованиеПриглашаются здоровые добровольцы

Возраст от 40 до 75 · Любой пол · Обновлено 2 окт. 2026 г. · NCT05334069

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Astera Cancer Care (Formerly Regional Cancer Care Associates), East Brunswick
Medical Oncology Hematology Associates, Newark

Набор участниковФаза 2

Возраст от 18 лет · Любой пол · Обновлено 1 окт. 2026 г. · NCT07102381

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer

Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
Memorial Sloan Kettering Monmouth (Consent Only), Middletown
Memorial Sloan Kettering Bergen (Consent Only), Montvale

Набор участников

Возраст от 18 лет · Любой пол · Обновлено 30 сент. 2026 г. · NCT07218250

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, New Brunswick

Набор участниковФаза 1

Возраст от 18 лет · Любой пол · Обновлено 29 сент. 2026 г. · NCT05877599

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack
Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 28 сент. 2026 г. · NCT07060807

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township

Набор участников

Возраст от 30 лет · Женщины · Обновлено 25 сент. 2026 г. · NCT02945579

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack
Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 25 сент. 2026 г. · NCT06966700

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Englewood Hospital, Englewood
Capital Health Medical Center - Hopewell, Pennington
Penn Medicine - Princeton Health, Plainsboro

Набор участниковФаза 3

Возраст от 60 лет · Любой пол · Обновлено 25 сент. 2026 г. · NCT06377852

A Study of Language Interpretation Solutions for People With Breast Cancer

Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
Memorial Sloan Kettering Monmouth (Consent Only), Middletown
Memorial Sloan Kettering Bergen (Consent Only), Montvale

Набор участников

Возраст от 18 лет · Любой пол · Обновлено 25 сент. 2026 г. · NCT06721065

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Набор участниковФаза 1

Возраст от 18 лет · Женщины · Обновлено 24 сент. 2026 г. · NCT05412225

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Набор участниковФаза 1/2

Возраст от 18 лет · Любой пол · Обновлено 23 сент. 2026 г. · NCT06618287

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Cooper Health, Camden
Rutgers, New Brunswick

Набор участников

Возраст от 18 лет · Любой пол · Обновлено 23 сент. 2026 г. · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Jefferson Health - Cherry Hill, Cherry Hill
Sidney Kimmel Cancer Center - Washington Township, Sewell
Atlantic Health System Overlook Medical Center, Summit

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 22 сент. 2026 г. · NCT07174336

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale

Набор участниковФаза 2

Возраст от 45 лет · Женщины · Обновлено 21 сент. 2026 г. · NCT04084730

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Summit Medical Group PA, Florham Park
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Long Branch
и еще 4

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 17 сент. 2026 г. · NCT07173751

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge
Summit Medical Group, Florham Park
Memorial Sloan Kettering Cancer Center Monmouth, Middletown
и еще 1

Набор участниковФаза 1/2

Возраст от 18 лет · Любой пол · Обновлено 17 сент. 2026 г. · NCT06827236

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

MD Anderson Cancer Center at Cooper, Camden
Summit Medical Group, Florham Park
John Theurer Ctr-Hackensack UMC, Hackensack
и еще 1

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 15 сент. 2026 г. · NCT06492616

A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Набор участниковФаза 1

Возраст от 18 лет · Любой пол · Обновлено 14 сент. 2026 г. · NCT06246968

A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery

Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

Набор участниковФаза 1/2

Возраст от 18 лет · Женщины · Обновлено 11 сент. 2026 г. · NCT05130801

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

START - New Jersey, East Brunswick

Набор участниковФаза 1

Возраст от 18 лет · Любой пол · Обновлено 10 сент. 2026 г. · NCT06293898

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Rutgers Cancer Institute, New Brunswick

Набор участниковФаза 1

Возраст от 18 лет · Любой пол · Обновлено 9 сент. 2026 г. · NCT06253871

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
Hackensack Meridian Health, Hackensack
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
и еще 1

Набор участниковФаза 2

Возраст от 18 лет · Любой пол · Обновлено 9 сент. 2026 г. · NCT05570253

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Rutgers Cancer Institute of New Jersey, New Brunswick

Набор участниковФаза 1/2

Возраст от 18 лет · Любой пол · Обновлено 8 сент. 2026 г. · NCT07100106

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

Astera Cancer Care East Brunswick, East Brunswick

Набор участниковФаза 2

Возраст от 18 лет · Любой пол · Обновлено 4 сент. 2026 г. · NCT07368998

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Rutgers Cancer Institute, New Brunswick

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 3 сент. 2026 г. · NCT06982521

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Summit Medical Group, Florham Park

Набор участниковНаблюдательное исследование

Возраст от 18 до 99 · Любой пол · Обновлено 3 сент. 2026 г. · NCT07211178

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Astera Cancer Care East Brunswick, East Brunswick
Summit Medical Group, Florham Park

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 3 сент. 2026 г. · NCT06790693

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Набор участниковНаблюдательное исследование

Возраст от 18 лет · Женщины · Обновлено 3 сент. 2026 г. · NCT05590949

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Набор участниковФаза 1/2

Возраст от 18 лет · Любой пол · Обновлено 2 сент. 2026 г. · NCT07287995

Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer

Cooper Hospital University Medical Center, Voorhees Township

Набор участниковФаза 2

Возраст от 18 лет · Любой пол · Обновлено 2 сент. 2026 г. · NCT07076485

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale

Набор участников

Возраст от 18 лет · Любой пол · Обновлено 2 сент. 2026 г. · NCT05837767

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Cooper Hospital University Medical Center, Camden
Jefferson Cherry Hill Hospital, Cherry Hill
Trinitas Hospital and Comprehensive Cancer Center - Williamson Street Campus, Elizabeth
и еще 21

Набор участниковФаза 3

Возраст от 18 до 60 · Женщины · Обновлено 2 сент. 2026 г. · NCT05879926

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Hunterdon Medical Center, Flemington

Набор участниковФаза 3

Возраст от 18 лет · Любой пол · Обновлено 2 сент. 2026 г. · NCT06072612

Study of Aerobic Training for People Receiving Treatment for Breast Cancer

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale

Набор участниковФаза 2

Возраст от 18 лет · Женщины · Обновлено 27 авг. 2026 г. · NCT05716893

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

START New Jersey, LLC, East Brunswick

Набор участниковФаза 1

Возраст от 18 лет · Любой пол · Обновлено 26 авг. 2026 г. · NCT07383506

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

Rutgers Cancer Institute, New Brunswick
RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick

Набор участниковФаза 1

Возраст от 18 лет · Любой пол · Обновлено 25 авг. 2026 г. · NCT05483491

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack

Набор участниковФаза 1

Возраст от 18 лет · Любой пол · Обновлено 21 авг. 2026 г. · NCT06774963

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale

Набор участниковФаза 2

Возраст от 18 лет · Любой пол · Обновлено 20 авг. 2026 г. · NCT07459673

Источник: ClinicalTrials.gov, данные получены 5 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.